Since the majority of TNBCs have been classified as basal breast cancers [41],[42], the reduced relapse-free survival in patients with high Toca-1 levels reported here is consistent with our functional studies implicating Toca-1 in promoting breast cancer cell invasion and tumor metastasis downstream of EGFR and Cdc42. This evidence concerns the gene FNBP1L and breast carcinoma.